Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy
Mesenchymal stem cells (MSCs) possess pleiotropic properties that include immunomodulation, inhibition of apoptosis, fibrosis and oxidative stress, secretion of trophic factors, and enhancement of angiogenesis. These properties provide a broad spectrum for their potential in a wide range of injuries...
Main Authors: | Janaina Paulini, Eliza Higuti, Rosana M. C. Bastos, Samirah A. Gomes, Érika B. Rangel |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/9521629 |
Similar Items
-
Failure of intrathecal allogeneic mesenchymal stem cells to halt progressive demyelination in two boys with cerebral adrenoleukodystrophy
by: Ashish Gupta, et al.
Published: (2020-05-01) -
Evaluation of Therapeutic Effects of Autologous Bone Marrow Mesenchymal Stem Cells to Prevent the Progression of Chronic Nephropathy in Renal Transplant
by: Ali Ghasemi, et al.
Published: (2014-05-01) -
Valsartan reduces NOX4 expression and halts diabetic nephropathy in streptozotocin induced diabetic rat model
by: Shymaa A. Maher, et al.
Published: (2019-08-01) -
Therapeutic Potential of Mesenchymal Stem Cells in a Pre-Clinical Model of Diabetic Kidney Disease and Obesity
by: Christian Sávio-Silva, et al.
Published: (2021-02-01) -
Mesenchymal stem cells prevent the progression of diabetic nephropathy by improving mitochondrial function in tubular epithelial cells
by: Seung Eun Lee, et al.
Published: (2019-07-01)